Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1)
•••
RPINVESTOR
X
View Profile
View Bullboard History
Comment by
RPINVESTOR
on Nov 21, 2022 5:49pm
RE:interest??
Tax loss selling season.
(15)
•••
bluemoons20
X
View Profile
View Bullboard History
Post by
bluemoons20
on Nov 21, 2022 4:22pm
interest??
on this plunge one of the biggest share volume days for years!!! I hope the end is not near GLTA
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(1)
•••
RPINVESTOR
X
View Profile
View Bullboard History
Comment by
RPINVESTOR
on Nov 21, 2022 12:44pm
RE:RE:RE:RE:Just a thought
BellEnd:- My letter to the British Columbia Securities Commission has the goal of putting Replicel Life Sciences Inc. on the radar of the Compliance Division. I tried to summarize some of the issues
...more
(1)
•••
RPINVESTOR
X
View Profile
View Bullboard History
Comment by
RPINVESTOR
on Nov 21, 2022 10:40am
RE:RE:Just a thought
I have just sent an e-mail to the British Columbia Securities Commission outlining my concerns. I suggest that anyone else who feels the same way also contact this regulatory agency.
(15)
•••
bluemoons20
X
View Profile
View Bullboard History
Comment by
bluemoons20
on Nov 20, 2022 9:33pm
RE:Just a thought
Possibly true. I think they know they have 'burned' the small investors and they do not like them. Then there is also the possibility mentioned
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Nov 18, 2022 10:32am
RE:RE:RE:RE:RE:RE:RE:How to contact lee?
JC apologies for the sarcastic tone of my last email but I found it humerous to compare Lee Buckler to Tim Cook and Elon Musk. Replicel has one fulltime employee: Lee Buckler and he has in the
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Nov 18, 2022 12:08am
RE:RE:RE:RE:RE:RE:How to contact lee?
Haha, so angry.. What in the world do you want to hear from them? Do you honestly think they are holding information hostage from us so none of the Replicel team gets paid? Does that seem
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Nov 17, 2022 11:29pm
RE:RE:RE:RE:RE:How to contact lee?
Hey JC this is not Tesla or Apple, it is little old Replicel. Give your head a shake. Where did you become the Lee Buckler defender ? I have read your shite disturbing tweets on
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Nov 17, 2022 11:11pm
RE:RE:RE:RE:How to contact lee?
He's the CEO - it's not like anyone can just call Tim Cook or Elon Musk to complain... if you want a public voice, use Twitter. what do we expect to hear from him when we all know
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Nov 17, 2022 7:00pm
RE:RE:RE:How to contact lee?
For someone that is paid $250,000 a year to be the CEO of this company he is a bit hard to get a hold of. All we hear from Lee Buckler these days is him Tweeting about some other biotech
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Nov 17, 2022 4:39pm
RE:How to contact lee?
FRom their website: E info@replicel.com T 604 248 8730
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Nov 17, 2022 4:11pm
RE:RE:How to contact lee?
But there are claims that he's on this site, which I highly doubt, but if you believe so, he is seeing all of this
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Nov 17, 2022 4:10pm
RE:How to contact lee?
Twitter - he sees everything
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Nov 16, 2022 10:59pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Buy Replicel Shares
AMEN ToniZ1 - I very much agree with everything you said x 100! Shiseido was hoping for Replicel to go belly up, but Andrew's deep pockets are saving the day. He will be rewarded handsomely
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >